Reports of cases of AIDS, HIV infection, and HIV/AIDS 1

Similar documents
HIV Surveillance in Women. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention

Community. Profile Yellowstone County. Public Health and Safety Division

Community. Profile Lewis & Clark County. Public Health and Safety Division

Community. Profile Missoula County. Public Health and Safety Division

Community. Profile Big Horn County. Public Health and Safety Division

Community. Profile Powell County. Public Health and Safety Division

Community. Profile Anaconda- Deer Lodge County. Public Health and Safety Division

Breast Cancer Statistics, 2013

Community. Profile Carter County. Public Health and Safety Division

Invasive Pneumococcal Disease Quarterly Report. July September 2017

Epidemiology of the Viral Hepatitis-HIV Syndemic in San Francisco: A Collaborative Surveillance Approach

XII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV

Appendix J Environmental Justice Populations

Urinary Tract Infection in Men

A Two-Stage Sampling Method for Clinical Surveillance of Individuals in Care for HIV Infection in the United States

Estimating the Cost to U.S. Health Departments to Conduct HIV Surveillance

Invasive Pneumococcal Disease Quarterly Report July September 2018

msmr MEDICAL SURVEILLANCE MONTHLY REPORT INSIDE THIS ISSUE: A publication of the Armed Forces Health Surveillance Center Summary tables and figures

Ethnic Disparities in Stroke Recognition in Individuals with Prior Stroke

Potassium Intake of the U.S. Population

Trends in Mortality From COPD Among Adults in the United States

Urinary Tract Infection in Women

Metabolic syndrome (MetS) is defined by a group

Supplementary Online Content

Cost-Effectiveness of Finding New HIV Diagnoses Using Rapid HIV Testing in Community-Based Organizations

Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria

Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites,

Between 45% and 85% of the approximately 4 million people

PNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :

Estimating the impact of the 2009 influenza A(H1N1) pandemic on mortality in the elderly in Navarre, Spain

CheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer

3.3 Verotoxigenic E. coli

The Centers for Disease

EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1

Area-Level Socioeconomic Disadvantage and Severe Pulmonary Tuberculosis: U.S.,

Supplementary Online Content

Assessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II

Anemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project

Rates of weight change for black and white Americans over a twenty year period

Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study

Relation of Tumor Size, Lymph Node Status, and Survival in

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Geographical influence on digit ratio (2D:4D): a case study of Andoni and Ikwerre ethnic groups in Niger delta, Nigeria.

University of Texas Health Science Center, San Antonio, San Antonio, Texas, USA

Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008

Hepatitis A virus (HAV) infection contributes approximately

DXA: Can It Be Used as a Criterion Reference for Body Fat Measurements in Children?

Longitudinal Association of Maternal Attempt to Lose Weight During the Postpartum Period and Child Obesity at Age 3 Years

A Four-System Comparison of Patients With Chronic Illness: The Military Health System, Veterans Health Administration, Medicaid, and Commercial Plans

Clinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number

Addendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)

SYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT

Using Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids

Not for Citation or Publication Without Consent of the Author

Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome Knowledge and Risk Factors in Ethiopian Military Personnel

There has been little systematic

Quantifying perceived impact of scientific publications

Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic

Prostate cancer is among the most common malignancies

BMI and Mortality: Results From a National Longitudinal Study of Canadian Adults

Effectiveness of Belt Positioning Booster Seats: An Updated Assessment

Diabetes affects 29 million Americans, imposing a substantial

Potential for Interactions Between Dietary Supplements and Prescription Medications a

Effects of age, density, and seasonality on molt pattern in the mammal genus (Peromyscus)

The Quality and Outcomes Framework (QOF) is a pay-for-performance

HEMOGLOBIN STANDARDS*

Seasonal influenza vaccination programme country profile: Ireland

May 28, Congressional Requesters

Detecting Undiagnosed Type 2 Diabetes: Family History as a Risk Factor and Screening Tool. Rodolfo Valdez, Ph.D.

Metformin and breast cancer stage at diagnosis: a population-based study

Opioid Use and Survival at the End of Life: A Survey of a Hospice Population

Water fl uoridation and dental caries in 5- and 12-year-old children from Canterbury and Wellington

Lifetime exercise activity and breast cancer risk among post-menopausal women

Risk of Colorectal Cancer by Subsite in a Swedish Prostate Cancer Cohort

Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians

key words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization

Factors influencing help seeking in mentally distressed young adults: a cross-sectional survey

Epidemiological survey and analysis of asthma in children aged 0-14 years old in urban and rural areas of Chengdu region

Inadequate health literacy is a

Single-Molecule Studies of Unlabelled Full-Length p53 Protein Binding to DNA

Colon Cancer Treatment: Are There Racial Disparities in an Equal-Access Healthcare System?

Soybean Hulls as an Alternative Feed for Horses

Reducing the Risk. Logic Model

ECONOMIC EVALUATION OF WATER IODIZATION PROGRAM IN THAILAND

Trends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?

The Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes

Cost of Child Lead Poisoning to Taxpayers in Mahoning County, Ohio

Safety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA

obesità nel bambino: epidemiologia e prevenzione

Original Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:

Presented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE

Fertility in Norwegian testicular cancer patients

Lifetime and 12-Month Prevalence of Psychiatric Disorders in 8,169 Male Vietnam War Era Veterans

Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012

Utilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E

phosphatase isoenzyme activity: estimation of

The Medium, Not the Message. How Tattoos Correlate With Early Mortality. Henry J. Carson, MD ABSTRACT

Authors: Ms. Joanne Cassar, Ms. Natasha Sindicich and Dr. Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales.

Transcription:

Reports of cses of AIDS, HIV infection, nd HIV/AIDS 1

The HIV/AIDS Surveillnce Report is published nnully by the Division of HIV/AIDS Prevention Surveillnce nd Epidemiology, Ntionl Center for HIV, STD, nd TB Prevention, Coordinting Center for Infectious Diseses, Centers for Disese Control nd Prevention, Atlnt, Georgi. All dt re provisionl. The HIV/AIDS Surveillnce Report is not copyrighted nd my be used nd copied without permission. Cittion of the source is, however, pprecited. Suggested cittion Centers for Disese Control nd Prevention. HIV/AIDS Surveillnce Report, 2004. Vol. 16. Atlnt: US Deprtment of Helth nd Humn Services, Centers for Disese Control nd Prevention; 2005:[inclusive pge numbers]. Also vilble t: http://www.cdc.gov/hiv/stts/hsrlink.htm. Centers for Disese Control nd Prevention... Julie Louise Gerberding, M.D., M.P.H. Director Coordinting Center for Infectious Diseses...Mitch Cohen, M.D. Director Ntionl Center for HIV, STD, nd TB Prevention... Ronld O. Vldiserri, M.D., M.P.H. Acting Director Division of HIV/AIDS Prevention Surveillnce nd Epidemiology... Robert S. Jnssen, M.D. Director HIV Incidence nd Cse Surveillnce Brnch... Mtthew T. McKenn, M.D., M.P.H. Chief Reporting, Anlysis, nd Evlution Tem... Kte Glynn, D.V.M. Tem Supervisor Reserch nd Dissemintion Tem... Michel Cmpsmith, D.D.S., M.P.H. Tem Supervisor Sttistics nd Dt Mngement Brnch... Timothy A. Green, Ph.D. Chief Single copies: CDC Ntionl Prevention Informtion Network, P.O. Box 6003, Rockville, MD 20849-6003 Telephone: 1-800-458-5231 or 1-301-562-1098 Request to be dded to miling list: CDC, MASO/MSB, Mil Stop F-07, 4770 Buford Highwy, Chmblee, GA 30341-3717 On the Web: http://www.cdc.gov, Select Publictions, Softwre & Products Confidentil informtion, referrls, nd eductionl mteril on HIV infection nd AIDS: CDC Ntionl AIDS Hotline, 1-800-342-2437, 1-800-344-7432 (Spnish), 1-800-243-7889 (TTY, def ccess) Acknowledgments: Publiction of this report would not hve been possible without the contributions of the Stte nd Territoril Helth Deprtments nd the HIV/AIDS Surveillnce Progrms which provided surveillnce dt to the Centers for Disese Control nd Prevention. This report ws prepred by the following stff nd contrctors of the Division of HIV/AIDS Prevention, Ntionl Center for HIV, STD, nd TB Prevention, Centers for Disese Control nd Prevention: Jnet Brzuskiewicz, Michel Cmpsmith, Robert Frey, Kte Glynn, Xiohong Hu, Denise Hughes, Lis M. Lee, Jinmin Li, Ktrin McGhee, Mtthew McKenn, Ann Stcher, nd Lynne Stockton. The HIV/AIDS design element on the cover is used with the permission of the Americn Red Cross. Federl Recycling Progrm Printed on recycled pper 2 Reports of cses of AIDS, HIV infection, nd HIV/AIDS

Contents Commentry... 5 Section 1 Cses of HIV/AIDS nd AIDS Tble 1. Estimted numbers of cses of HIV/AIDS, by yer of dignosis nd selected chrcteristics of persons, 2001 2004 35 res with confidentil nme-bsed HIV infection reporting... 10 Tble 2. Estimted distribution of persons with nd persons without dignosis of AIDS within 12 months of dignosis of HIV infection, by selected chrcteristics, 2003 35 res with confidentil nme-bsed HIV infection reporting...11 Tble 3. Estimted numbers of AIDS cses, by yer of dignosis nd selected chrcteristics of persons, 2000 2004 United Sttes... 12 Tble 4. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis nd trnsmission ctegory, 2000 2004 United Sttes... 13 Figure 1. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis, 1992 2004 United Sttes... 13 Tble 5. Estimted numbers of cses nd rtes (per 100,000 popultion) of AIDS, by rce/ethnicity, ge ctegory, nd sex, 2004 50 sttes nd the District of Columbi... 14 Tble 5b. Estimted numbers of cses nd rtes (per 100,000 popultion) of HIV/AIDS, by rce/ethnicity, ge ctegory, nd sex, 2004 33 sttes with confidentil nme-bsed HIV infection reporting... 14 Tble 6. Estimted numbers of AIDS cses in dult nd dolescent Hispnics, by trnsmission ctegory nd plce of birth, 2004 United Sttes... 15 Section 2 Deths Tble 7. Estimted numbers of deths of persons with AIDS, by yer of deth nd selected chrcteristics, 2000 2004 United Sttes... 16 Section 3 Persons living with HIV/AIDS, AIDS, or HIV infection Tble 8. Estimted numbers of persons living with HIV/AIDS, by yer nd selected chrcteristics, 2001 2004 35 res with confidentil nme-bsed HIV infection reporting... 17 Tble 9. Estimted numbers of persons living with HIV/AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory 35 res with confidentil nme-bsed HIV infection reporting... 18 Mp 1. Estimted rtes for dults nd dolescents living with HIV infection (not AIDS) or with AIDS (per 100,000 popultion), 2004 United Sttes... 19 Mp 2. Estimted rtes for children <13 yers of ge living with HIV infection (not AIDS) or with AIDS (per 100,000 popultion), 2004 United Sttes... 19 Tble 10. Estimted numbers of persons living with AIDS, by yer nd selected chrcteristics, 2000 2004 United Sttes... 20 Tble 11. Estimted numbers of persons living with AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory United Sttes... 21 Tble 12. Estimted numbers of persons living with HIV infection (not AIDS) or with AIDS t the end of 2004, by re of residence nd ge ctegory United Sttes... 22 Reports of cses of AIDS, HIV infection, nd HIV/AIDS 3

Section 4 Survivl fter AIDS dignosis Tble 13. Proportion of persons surviving for more thn 12, 24, nd 36 months fter n AIDS dignosis in 2000, by selected chrcteristics United Sttes... 24 Figure 2. Proportion of persons surviving, by months fter AIDS dignosis during 1996 2003 nd by yer of dignosis United Sttes... 25 Figure 3. Proportion of persons surviving, by months fter AIDS dignosis during 1996 2003 nd by ge group United Sttes... 25 Figure 4. Proportion of persons surviving, by months fter AIDS dignosis during 1996 2003 nd by rce/ethnicity United Sttes... 26 Section 5 Reports of cses of AIDS, HIV infection, nd HIV/AIDS Tble 14. Reported AIDS cses nd nnul rtes (per 100,000 popultion), by re of residence nd ge ctegory, cumultive through 2004 United Sttes... 27 Tble 15. Reported AIDS cses nd nnul rtes (per 100,000 popultion), by metropolitn re of residence nd ge ctegory, cumultive through 2004 United Sttes... 29 Tble 16. Reported cses of HIV infection (not AIDS), by re of residence nd ge ctegory, cumultive through 2004 42 res with confidentil nme-bsed HIV infection reporting... 31 Tble 17. Reported AIDS cses, by ge ctegory, trnsmission ctegory, nd sex, cumultive through 2004 United Sttes... 32 Tble 18. Reported cses of HIV infection (not AIDS), by ge ctegory, trnsmission ctegory, nd sex, cumultive through 2004 42 res with confidentil nme-bsed HIV infection reporting... 33 Tble 19. Reported AIDS cses for mle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 United Sttes... 34 Tble 20. Reported cses of HIV infection (not AIDS) for mle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 42 res with confidentil nme-bsed HIV infection reporting... 35 Tble 21. Reported AIDS cses for femle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 United Sttes... 36 Tble 22. Reported cses of HIV infection (not AIDS) for femle dults nd dolescents, by trnsmission ctegory nd rce/ethnicity, cumultive through 2004 42 res with confidentil nme-bsed HIV infection reporting... 37 Tble 23. Reported cses of HIV/AIDS in infnts born to HIV-infected mothers, by yer of report nd selected chrcteristics, 1994 2004 25 sttes with confidentil nme-bsed HIV infection reporting... 38 Technicl Notes... 39 Web ddresses for stte HIV Infection nd AIDS Surveillnce Reports... 46 4 Reports of cses of AIDS, HIV infection, nd HIV/AIDS

Commentry To better monitor the ptterns of HIV dignoses, ll sttes hve implemented HIV surveillnce. This report presents estimted numbers of cses of HIV/ AIDS from the 35 res (33 sttes, Gum, nd the U.S. Virgin Islnds) with integrted HIV nd AIDS surveillnce since t lest 2000. Two of these res begn integrted surveillnce in 2000: Gum nd New York. New York is the stte with the highest reported percentge (18%) of cumultive ntionl AIDS cses, nd inclusion of their integrted dt resulted in lrge numeric increses in the estimted number of HIV/ AIDS cses compred to previous HIV/AIDS surveillnce reports. From 2001 through 2004, the totl number of new cses of HIV/AIDS in the 35 res decresed slightly; however, HIV/AIDS prevlence (i.e., the number of persons living with HIV/AIDS) incresed during this time: t the end of 2004, n estimted 462,792 persons in the 35 res were dignosed nd living with HIV/AIDS. According to the number of reported AIDS cses, these 35 res represent pproximtely 61% of the epidemic in the United Sttes. The mp on the cover depicts the estimted number of cses of HIV/AIDS in 2004, by re of residence t dignosis, for persons residing in the 33 sttes with integrted HIV nd AIDS surveillnce. Surveillnce dt on HIV infections provide more complete picture of the epidemic nd the need for prevention nd cre services thn does the picture provided by AIDS dt lone. However, the number of new HIV dignoses does not necessrily reflect trends in HIV incidence (i.e., new infections) becuse some newly dignosed persons were infected recently while others were infected some time in the pst. One method for estimting HIV incidence is to pply the serologic testing lgorithm for recent HIV seroconversion (STARHS) to the serum specimens from which new HIV dignoses were mde. A totl of 34 res re using this method to estimte popultion-bsed HIV incidence: 5 res were funded in FY 2002 to pilot this method, 19 res were funded in FY 2003, nother 9 res were funded in FY 2004 nd one dditionl re ws funded in FY 2005. The monitoring of HIV incidence will be criticl in evluting progress towrd CDC s HIV Prevention Strtegic Pln gol of reducing the number of new HIV infections in the United Sttes from 40,000 to 20,000 per yer, to llocte resources nd evlute prevention progrm effectiveness. In 2002, CDC initited the Interstte Dupliction Evlution Project (IDEP), forml evlution compring HIV/AIDS records in the ntionl dtbse cross sttes in order to identify potentil duplicte cses. Current IDEP de-dupliction efforts were completed in December 2004, nd pproximtely 40,000 HIV/AIDS cses were found to be duplictes (representing less thn 5% of lmost 1 million cses tht hve been reported to CDC over the course of the epidemic); these duplicte cses hve been removed from the ntionl surveillnce dtbse nd from individul stte surveillnce dtbses. As result of this correction there my be minor reductions in reported cses displyed in this surveillnce report compred to the previous HIV/ AIDS surveillnce report. The 2004 HIV/AIDS Surveillnce Report presents dt on cses of HIV/AIDS. For nlyses of HIV/AIDS dt, we used dt from 35 res (i.e., 33 sttes, Gum, nd the U.S. Virgin Islnds) with mture HIV reporting systems (i.e., HIV reporting t lest since 2000) to llow for stbiliztion of dt collection nd for djustment of the dt in order to monitor trends. Tbles 1, 2, 8, nd 9 summrize cses nd prevlence of HIV/AIDS. For nlyses of AIDS cses, we used dt from the 50 sttes, the District of Columbi, U.S. dependencies, possessions, nd ssocited ntions. This report is orgnized in 5 sections: (1) cses of HIV/AIDS nd AIDS, (2) deths of persons with AIDS, (3) persons living with HIV/AIDS, AIDS, or HIV infection (not AIDS), (4) length of survivl fter AIDS dignosis, nd (5) reports of cses of AIDS, HIV infection (not AIDS), nd HIV/AIDS. In Sections 1 3, we present point estimtes of cse counts tht hve been djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. CDC routinely djusts dt for the presenttion of trends in the epidemic. Dt to estimte the number of cses of HIV/AIDS or AIDS; the number of persons living with HIV/AIDS, AIDS, or HIV infection (not AIDS); nd the number of deths mong persons with AIDS hve been sttisticlly djusted to correct for delys in the reporting of cses nd deths. To ssess trends in cses, deths, or prevlence, it is preferble to use djusted dt, presented by yer of dignosis insted of yer of report, to eliminte rtifcts of reporting in the surveillnce system. Therefore, for trends, the Reports of cses of AIDS, HIV infection, nd HIV/AIDS 5

reder is encourged to use the tbles in Sections 1 3 tht present trends by yer of dignosis, yer of deth, or yer-end prevlence. Section 4 presents estimtes of survivl for persons whose AIDS dignosis ws mde during 2000 (Tble 13) nd for persons whose dignosis ws mde during 1996 2003 (Figures 2 4). Proportions of persons who survived for vrious lengths of time fter dignosis re presented by yer of dignosis, ge group, rce/ ethnicity, nd HIV trnsmission ctegory. Finlly, Section 5 presents reports of cses of HIV infection (not AIDS) nd cses of AIDS reported through 2004. The res included in tbultions of reported cses of HIV infection (not AIDS) re bsed on the dte tht confidentil nme-bsed HIV infection reporting ws implemented. For Tbles 16, 18, 20, nd 22, we used dt from 42 res to describe reports of HIV infection. These dt hve not been djusted for delys in reporting nd re presented by yer of report to CDC. Tbles tht present cses by yer of report represent the most up-to-dte informtion reported to CDC; however, cses by yer of report do not represent incident cses, the most recent dignoses, trends, or deths. Highlights of Anlyses Cses of HIV/AIDS nd cses of AIDS Cses of HIV/AIDS The estimted number of HIV/AIDS cses in the 35 res with confidentil nme-bsed HIV infection reporting decresed yer to yer from 2001 through 2003 nd then incresed pproximtely 1% from the end of 2003 (38,188) through the end of 2004 (38,730). Age group: From 2001 through 2004, the estimted number of HIV/AIDS cses decresed mong children less thn 13 yers of ge nd in the following ge groups: 13 14, 30 34, 35 39, 40 44, nd 45 49. The estimted number of HIV/AIDS cses remined stble in the ge group 25 29 yers, nd incresed in the following ge groups: 15 19, 20 24, 50 54, 55 59, 60 64, nd 65 yers nd older. The lrgest number of HIV/AIDS cses occurred mong persons ge 35 39 yers nd ccounted for 17% of ll HIV/ AIDS cses dignosed in 2004. Rce/ethnicity: From 2001 through 2004, the estimted number of HIV/AIDS cses incresed mong whites, Asins/Pcific Islnders, nd Americn Indins/Alsk Ntives, nd decresed mong blcks nd Hispnics. Blcks ccounted for 50% of ll HIV/AIDS cses dignosed in 2004. Sex: From 2001 through 2004, the estimted number of HIV/AIDS cses decresed pproximtely 2% mong mles nd 15% mong femles. In 2004, mles ccounted for 73% of ll HIV/AIDS cses mong dults nd dolescents. Trnsmission ctegory: From 2001 through 2004, the estimted number of HIV/AIDS cses incresed mong men who hve sex with men (MSM). The estimted number of HIV/AIDS cses decresed mong injection drug users (IDUs), MSM who were lso IDUs, heterosexul dults nd dolescents, nd mong children. MSM (47%) nd persons exposed through heterosexul contct (33%) ccounted for 80% of ll HIV/AIDS cses dignosed in 2004. Of ll HIV infections dignosed in 2003, 39% progressed to AIDS within 12 months fter HIV infection ws dignosed. AIDS ws dignosed within 12 months fter the dignosis of HIV infection for lrger proportion of persons ged 35 yers nd older, IDUs, nd persons exposed through heterosexul contct (Tble 2). Cses of AIDS During 2000 2001, decreses in nnul AIDS cses begn to level; however, fter 2001, the estimted number of AIDS cses incresed ech yer (Tble 3). In 2004, the estimted rte of AIDS cses in the United Sttes ws 14.1 per 100,000 popultion (Tble 5). Age group: From 2000 through 2004, the estimted number of AIDS cses decresed 61% mong children less thn 13 yers of ge, 11% in the ge group 30 34, nd 10% in the ge group 35 39 yers, nd remined stble in the ge group 13 14 yers (Tble 3). The estimted number of AIDS cses incresed in the following ge groups: 15 19, 20 24, 25 29, 40 44, 45 49, 50 54, 55 59, 60 64, nd 65 yers nd older. The lrgest number of AIDS cses occurred mong persons ge 40 44 yers nd ccounted for 21% of ll AIDS cses dignosed in 2004. Rce/ethnicity: From 2000 through 2004, the estimted number of AIDS cses incresed mong ll rcil nd ethnic groups (Tble 3). In 2004, rtes of AIDS cses were 56.4 per 100,000 in the blck popultion, 18.6 per 100,000 in the 6 Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS

Hispnic popultion, 7.9 per 100,000 in the Americn Indin/Alsk Ntive popultion, 6.0 per 100,000 in the white popultion, nd 3.7 per 100,000 in the Asin/Pcific Islnder popultion (Tble 5). Sex: From 2000 through 2004, the estimted number of AIDS cses incresed 10% mong femles nd 7% mong mles. Mles ccounted for 73% of ll AIDS cses dignosed in 2004 mong dults nd dolescents in the United Sttes (Tble 3). Rtes of AIDS cses in 2004 were 25.6 per 100,000 mong mles nd 9.0 per 100,000 mong femles (Tble 5). Trnsmission ctegory: From 2000 through 2004, the estimted number of AIDS cses decresed mong IDUs nd mong MSM who were lso IDUs (Tble 3). From 2000 through 2004, the estimted number of AIDS cses incresed mong MSM. Among persons exposed through heterosexul contct, the estimted number of AIDS cses incresed ech yer from 2000 through 2004. Region: From 2000 through 2004, the estimted number of AIDS cses incresed 25% in the South nd 13% in the Midwest, nd decresed 8% in the Northest, 6% in the West, nd 15% in the U.S. dependencies, possessions, nd ssocited ntions. Deths The estimted number of deths mong persons with AIDS decresed 8% from 2000 through 2004 (Tble 7). Age group: From 2000 through 2004, the estimted number of deths decresed mong children less thn 13 yers of ge nd in the following ge groups: 15 19, 25 29, 30 34, 35 39, 40 44, nd 45 49. The estimted number of deths incresed in the ge groups 13 14, 20 24, 50 54, 55 59, 60 64, nd 65 yers nd older. Rce/ethnicity: From 2000 through 2004, the estimted number of deths mong persons with AIDS decresed mong whites, blcks, nd Asins/Pcific Islnders nd incresed mong Hispnics nd Americn Indins/Alsk Ntives. Sex nd trnsmission ctegory: From 2000 through 2004, mong mles, the estimted number of deths of MSM nd IDUs decresed. Among femles, the estimted number of deths of IDUs decresed. The estimted number of deths incresed from 2000 through 2004 mong dults nd dolescents of both sexes exposed through heterosexul contct. Region: The estimted number of deths in 2004 compred with 2003 decresed in the Northest nd the Midwest; remined stble in the West nd incresed in the South, nd U.S. dependencies, possessions, nd ssocited ntions. Persons living with HIV/AIDS, HIV infection (not AIDS), or AIDS Persons living with HIV/AIDS The estimted number of persons living with HIV/AIDS hs incresed stedily in the 35 res with confidentil nme-bsed HIV infection reporting (Tble 8). At the end of 2004, n estimted 462,792 persons were living with HIV/AIDS in the 35 res with confidentil nme-bsed HIV infection reporting since 2000: By ge group, the most cses (22%) were in the ge group 40 44 yers. By rce/ethnicity, 48% were blck, 34% white, 17% Hispnic, nd less thn 1% ech were Americn Indin/Alsk Ntive nd Asin/ Pcific Islnder. By sex, 73% of dults nd dolescents living with HIV/AIDS were mle. Of the estimted 332,578 mle dults nd dolescents living with HIV/AIDS, 60% were MSM, 19% were IDUs, 13% hd been exposed through heterosexul contct, nd 7% were MSM who lso were IDUs. Of the estimted 123,405 femle dults nd dolescents living with HIV/ AIDS, 71% hd been exposed through heterosexul contct, nd 27% hd been exposed through injection drug use. Of the estimted 6,804 children living with HIV/AIDS, 90% hd been exposed perintlly. Prevlence rtes of HIV infection (not AIDS) In the 35 res with confidentil nme-bsed HIV infection reporting, the prevlence rte of HIV infection (not AIDS) mong dults nd dolescents ws estimted t 136.7 per 100,000 t the end of 2004 (Mp 1). The rte for dults nd dolescents living with HIV infection (not AIDS) rnged from n estimted 15.0 per 100,000 (North Dkot) to n estimted 281.7 per 100,000 (U.S. Virgin Islnds). The prevlence rte of HIV infection (not AIDS) mong children residing in the 35 res ws n estimted 7.9 per 100,000 t the end of 2004 (Mp 2). Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS 7

The rte for children living with HIV infection (not AIDS) rnged from n estimted zero per 100,000 in New Mexico, North Dkot, nd Gum, to n estimted 32.3 per 100,000 in New York. Persons living with AIDS AIDS prevlence hs lso incresed stedily since 2000 (Tble 10). At the end of 2004, n estimted 415,193 persons in the United Sttes were living with AIDS: By ge group, the most cses (23%) were in the ge group 40 44 yers. By rce/ethnicity, 43% were blck, 35% white, 20% Hispnic, 1% Asin/Pcific Islnder nd less thn 1% Americn Indin/Alsk Ntive. By sex, 77% of dults nd dolescents living with AIDS were mle. By region, 39% resided in the South, 29% in the Northest, 19% in the West, 10% in the Midwest, nd 3% in the U.S. dependencies, possessions, nd ssocited ntions. Of the estimted 317,698 mle dults nd dolescents living with AIDS, 58% were MSM, 21% were IDUs, 11% hd been exposed through heterosexul contct, nd 8% were MSM who were lso IDUs. Of the estimted 93,566 femle dults nd dolescents living with AIDS, 64% hd been exposed through heterosexul contct, nd 34% hd been exposed through injection drug use. AIDS prevlence rtes In the United Sttes, the prevlence rte of AIDS mong dults nd dolescents ws estimted t 168.8 per 100,000 t the end of 2004 (Mp 1). The rte for dults nd dolescents living with AIDS rnged from n estimted 4 per 100,000 (U.S. Pcific Islnds) to n estimted 1,906 per 100,000 (District of Columbi). The prevlence rte of AIDS mong children in the United Sttes ws estimted t 3.2 per 100,000 t the end of 2004 (Mp 2). The rte for children living with AIDS rnged from n estimted zero per 100,000 in Gum, Idho, Montn, Uth, nd the U.S. Pcific Islnds to n estimted 52.8 per 100,000 in the District of Columbi. Survivl fter AIDS dignosis Tble 13 is limited to dt on AIDS cses dignosed in 2000 in order to describe the survivl of persons whose dignosis ws mde reltively recently, but fr enough in the pst to permit meningful mesure of survivl. Figures 2, 3, nd 4 illustrte the proportion of surviving persons mong persons whose dignoses were mde over longer period, 1996 through 2003. Survivl (the estimted proportion of persons surviving given length of time fter dignosis) incresed with the yer of dignosis for dignoses mde during 1996 1999. Yer-to-yer differences were smll during 1999 2003 (Figure 2). Survivl decresed s ge t dignosis incresed mong persons t lest 35 yers old t dignosis nd in comprison with persons younger thn 35. Survivl ws similr for the ge groups 13 24 nd 25 34. Survivl ws gretest mong children less thn 13 yers of ge t dignosis (Figure 3). Survivl ws gretest mong MSM nd mong children with perintlly cquired HIV infection (Tble 13). Survivl ws intermedite mong men nd women who hd heterosexul contct with someone known to be HIV infected or t high risk for HIV infection, s well s mong MSM who lso were IDUs. Survivl ws lowest mong men nd women who were IDUs. Survivl, prticulrly t more thn 48 months fter dignosis, ws greter mong Asins/ Pcific Islnders, whites, nd Hispnics, thn mong blcks (Figure 4). Results were unstble or inconsistent for Americn Indins/Alsk Ntives becuse the numbers of persons in this rcil/ethnic ctegory were smll. Reports of Cses of AIDS, HIV infection (not AIDS), nd HIV/AIDS Tbles 14 23 describe reports of cses of AIDS, HIV infection (not AIDS), nd of HIV/AIDS. Tbles 16, 18, 20, nd 22 re bsed on reports of cses of HIV infection (not AIDS) through 2004 from the 42 res tht hd implemented nme-bsed HIV infection reporting. Note tht not ll cses of HIV infection (not AIDS) or AIDS reported in 2004 reflected new dignoses; rther, the reported cses include cses dignosed during erlier yers. Reports of cses of HIV infection (not AIDS) Through 2004, totl of 229,411 persons were reported s hving HIV infection (not AIDS) in the 42 res with confidentil nme-bsed HIV infection reporting (Tble 16). Five sttes (New York, Florid, 8 Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS

Texs, New Jersey, nd North Crolin) reported 121,787 (53%) of the 229,411 cumultive cses of HIV infection (not AIDS) reported to CDC. In 2004, 3 sttes (New York, Florid, nd Texs) reported 15,283 (46%) of the 33,563 cses of HIV infection (not AIDS). By sex, in 2004, 70% of the 33,132 reported cses of HIV infection (not AIDS) mong dults nd dolescents were in mles, nd 30% were in femles (Tble 18). In 2004, 431 cses of HIV infection (not AIDS) in children were reported. Reports of AIDS cses Through 2004, totl of 918,286 persons hd been reported s hving AIDS in the United Sttes, dependencies, possessions, nd ssocited ntions (Tble 14). Three sttes (Cliforni, Florid, nd New York) reported 43% of the cumultive AIDS cses, nd 41% of AIDS cses reported to CDC in 2004. In the United Sttes, the rte of reported AIDS cses in 2004 ws 15.0 per 100,000 popultion. The rte of reported AIDS cses rnged from zero per 100,000 (U.S. Pcific Islnds) to 179.2 per 100,000 (District of Columbi). By sex, in 2004, mles ccounted for 73% nd femles for 27% of 44,615 reported AIDS cses mong dults nd dolescents (Tble 17). In 2004, 122 AIDS cses in children were reported. Additionl Resources The following were prepred by using HIV/AIDS surveillnce dt: Selected MMWR rticles t www.cdc.gov/hiv/ pubs/mmwr.htm Public-use slides t www.cdc.gov/hiv/ grphics.htm Other surveillnce reports t www.cdc.gov/hiv/ stts/hsrlink.htm Public-use version of the AIDS surveillnce dt set (AIDS Public Informtion Dt Set [APIDS]) t www.cdc.gov/hiv/softwre/pids.htm Suggested Redings CDC. Advncing HIV prevention: new strtegies for chnging epidemic United Sttes, 2003. MMWR 2003;52:329-332. CDC. Dignosis nd reporting of HIV nd AIDS in 25 sttes United Sttes, 1994 2000. MMWR 2002;51:595-598. CDC. Guidelines for ntionl HIV cse surveillnce, including monitoring for HIV infection nd AIDS. MMWR 1999;48(No. RR-13):1-31. CDC. HIV Prevention Strtegic Pln Through 2005. Atlnt: U.S. Deprtment of Helth nd Humn Services, CDC; 2001. Avilble t http:// www.cdc.gov/hiv/prtners/psp.htm. CDC. Increses in HIV dignoses 29 sttes, 1999 2002. MMWR 2003;52:1145-1148. CDC. Updte: the AIDS epidemic in the United Sttes, 2001. MMWR 2002;51:592-595. Jnssen RS, Stten GA, Strmer SL, et l. New testing strtegy to detect erly HIV-1 infection for use in incidence estimtes nd for clinicl nd prevention purposes. JAMA 1998;280:42-48. Kron JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United Sttes t the turn of the century: n epidemic in trnsition. Am J Public Helth 2001;91:1060-1068. Nkshim AK, Fleming PL. HIV/AIDS surveillnce in the United Sttes, 1981 2001. J Acquir Immune Defic Syndr 2003;32:68-85. CDC. Dignoses of HIV/AIDS 32 sttes, 2000 2003. MMWR 2004;53:1106-1110. Reports of cses of AIDS, Commentry HIV infection, nd HIV/AIDS 9

Tble 1. Estimted numbers of cses of HIV/AIDS, by yer of dignosis nd selected chrcteristics of persons, 2001 2004 35 res with confidentil nme-bsed HIV infection reporting Yer of dignosis 2001 2002 2003 2004 Age t dignosis (yrs) < 13 360 288 203 174 13 14 53 46 53 41 15 19 1,012 1,023 1,027 1,080 20 24 3,241 3,154 3,345 3,762 25 29 4,608 4,499 4,290 4,604 30 34 6,776 6,305 5,688 5,527 35 39 8,261 7,719 7,112 6,754 40 44 6,699 6,395 6,483 6,344 45 49 4,709 4,486 4,514 4,536 50 54 2,735 2,643 2,733 2,776 55 59 1,411 1,330 1,414 1,594 60 64 730 763 705 804 65 674 627 623 734 Rce/ethnicity White, not Hispnic 11,242 11,352 11,097 11,806 Blck, not Hispnic 21,556 20,237 19,310 19,206 Hispnic 7,714 6,964 7,078 6,970 Asin/Pcific Islnder 279 319 367 394 Americn Indin/Alsk Ntive 171 202 187 208 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 16,625 16,852 16,804 18,203 Injection drug use 5,171 4,379 4,177 3,828 Mle-to-mle sexul contct nd injection drug use 1,525 1,431 1,398 1,372 Heterosexul contct 5,095 4,843 4,720 4,581 Other 214 183 179 161 Subtotl 28,630 27,689 27,279 28,143 Femle dult or dolescent Injection drug use 2,877 2,408 2,252 2,134 Heterosexul contct 9,192 8,709 8,248 8,102 Other 211 187 205 174 Subtotl 12,280 11,303 10,706 10,410 Child (<13 yrs t dignosis) Perintl 306 245 186 145 Other b 54 44 18 32 Subtotl 360 288 204 177 Subtotl for 33 sttes with confidentil nme-bsed HIV infection reporting 41,207 39,222 38,139 38,685 Subtotl for U.S. dependencies, possessions, nd ssocited ntions with confidentil nme-bsed HIV infection reporting 63 58 49 45 Totl c 41,270 39,280 38,188 38,730 Cumultive Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. b Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. c Includes persons of unknown rce or multiple rces nd persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 10 Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDSnd HIV/AIDS

Tble 2. Estimted distribution of persons with nd persons without dignosis of AIDS within 12 months of dignosis of HIV infection, by selected chrcteristics, 2003 35 res with confidentil nme-bsed HIV infection reporting AIDS dignoses 12 Months <12 Months fter dignosis fter dignosis of HIV infection of HIV infection Totl No. (%) No. (%) No. (%) Age t dignosis (yrs) <13 163 80 40 20 203 100 13 14 37 70 16 30 53 100 15 19 880 86 145 14 1,026 100 20 24 2,649 79 691 21 3,340 100 25 29 3,050 71 1,232 29 4,283 100 30 34 3,547 62 2,134 38 5,681 100 35 39 4,077 57 3,024 43 7,101 100 40 44 3,710 57 2,761 43 6,471 100 45 49 2,421 54 2,091 46 4,513 100 50 54 1,404 51 1,327 49 2,731 100 55 59 733 52 679 48 1,412 100 60 64 327 46 377 54 705 100 65 258 41 365 59 623 100 Rce/ethnicity White, not Hispnic 6,856 62 4,234 38 11,090 100 Blck, not Hispnic 11,682 61 7,603 39 19,285 100 Hispnic 4,279 61 2,785 39 7,063 100 Asin/Pcific Islnder 229 62 139 38 367 100 Americn Indin/Alsk Ntive 120 65 66 35 187 100 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 10,428 62 6,354 38 16,782 100 Injection drug use 2,224 53 1,948 47 4,172 100 Mle-to-mle sexul contct nd injection drug use 828 59 569 41 1,397 100 Heterosexul contct 2,586 55 2,125 45 4,710 100 Other b 75 42 104 58 179 100 Subtotl 16,140 59 11,101 41 27,241 100 Femle dult or dolescent Injection drug use 1,422 63 830 37 2,252 100 Heterosexul contct 5,426 66 2,815 34 8,240 100 Other b 108 53 97 47 205 100 Subtotl 6,956 65 3,742 35 10,697 100 Child (<13 yrs t dignosis) Perintl 147 79 39 21 186 100 Other c 16 92 1 8 18 100 Subtotl 163 80 41 20 204 100 Totl d 23,259 61 14,883 39 38,142 100 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons in whom AIDS hs developed nd persons whose first dignosis of HIV infection nd the dignosis of AIDS were mde t the sme time. Dt exclude 46 persons whose month of dignosis of HIV infection is unknown. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Percentges represent proportions of the totl number of dignoses of HIV/AIDS mde during 2003 for the corresponding group (see row entries). Becuse row totls were clculted independently of the vlues for the subpopultions, the vlues in ech row my not sum to the row totl. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes 149 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDS nd HIV/AIDS 11

Tble 3. Estimted numbers of AIDS cses, by yer of dignosis nd selected chrcteristics of persons, 2000 2004 United Sttes Yer of dignosis Cumultive 2000 2001 2002 2003 2004 through 2004 Age t dignosis (yrs) <13 124 115 109 69 48 9,443 13 14 60 79 71 58 60 959 15 19 291 274 312 301 326 4,936 20 24 1,329 1,343 1,467 1,664 1,788 34,164 25 29 3,432 3,239 3,279 3,276 3,576 114,642 30 34 6,497 6,258 6,010 6,003 5,786 195,404 35 39 8,930 8,649 8,716 8,763 8,031 208,199 40 44 7,530 7,502 7,825 8,291 8,747 161,964 45 49 5,200 5,401 5,656 6,102 6,245 99,644 50 54 3,007 3,199 3,436 3,672 3,932 54,869 55 59 1,528 1,567 1,718 1,854 2,079 29,553 60 64 833 820 930 929 996 16,119 65 752 759 738 848 901 14,410 Rce/ethnicity White, not Hispnic 11,378 11,052 11,604 11,657 12,013 375,155 Blck, not Hispnic 19,510 19,473 19,934 20,685 20,965 379,278 Hispnic 7,957 7,974 7,907 8,632 8,672 177,164 Asin/Pcific Islnder 350 381 440 478 488 7,317 Americn Indin/Alsk Ntive 175 169 186 189 193 3,084 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 15,374 15,510 16,442 17,139 17,691 441,380 Injection drug use 7,036 6,447 6,247 6,213 5,968 176,162 Mle-to-mle sexul contct nd injection drug use 2,102 2,056 1,982 1,996 1,920 64,833 Heterosexul contct 4,162 4,440 4,771 4,967 5,149 59,939 Other b 300 290 288 263 298 14,085 Subtotl 28,974 28,743 29,730 30,578 31,024 756,399 Femle dult or dolescent Injection drug use 3,393 3,175 3,008 3,068 3,184 72,651 Heterosexul contct 6,785 6,930 7,181 7,859 7,979 99,175 Other b 237 243 240 257 279 6,636 Subtotl 10,415 10,348 10,429 11,184 11,442 178,463 Child (<13 yrs t dignosis) Perintl 122 113 105 68 47 8,779 Other c 2 3 4 1 0 664 Subtotl 124 115 109 69 48 9,443 Region of residence Northest 12,105 11,212 10,395 11,149 11,158 289,792 Midwest 3,968 3,949 4,303 4,495 4,498 93,701 South 15,841 16,598 17,751 18,612 19,792 343,449 West 6,443 6,258 6,745 6,474 6,083 187,730 U.S. dependencies, possessions, nd ssocited ntions 1,156 1,190 1,073 1,100 982 29,634 Totl d 39,513 39,206 40,267 41,831 42,514 944,306 39,513 39,206 40,267 41,831 42,514 944,306 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes persons with dignosis of AIDS from the beginning of the epidemic through 2004. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes persons of unknown rce or multiple rces nd persons of unknown sex. Cumultive totl includes 2,308 persons of unknown rce or multiple rces nd 2 persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 12 Reports of Cses cses of HIV/AIDS AIDS, nd infection, AIDS nd HIV/AIDS

Tble 4. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis nd trnsmission ctegory, 2000 2004 United Sttes Yer of dignosis Cumultive 2000 2001 2002 2003 2004 through 2004 Rce/ethnicity White, not Hispnic 11 13 14 12 7 1,612 Blck, not Hispnic 93 79 71 43 29 5,590 Hispnic 18 22 21 12 8 2,128 Asin/Pcific Islnder 2 1 1 0 1 53 Americn Indin/Alsk Ntive 0 0 1 1 1 34 Trnsmission ctegory Hemophili/cogultion disorder 0 0 0 0 0 230 Mother with the following risk fctor for, or documented, HIV infection 122 113 105 68 47 8,779 Injection drug use 23 14 9 9 5 3,338 Sex with injection drug user 15 7 4 7 2 1,524 Sex with bisexul mle 3 3 3 0 2 201 Sex with person with hemophili 0 1 0 0 0 37 Sex with HIV-infected trnsfusion recipient 0 0 0 0 0 27 Sex with HIV-infected person, risk fctor not specified 35 36 38 20 18 1,515 Receipt of blood trnsfusion, blood components, or tissue 2 1 2 1 0 152 Hs HIV infection, risk fctor not specified 45 49 48 31 19 1,984 Receipt of blood trnsfusion, blood components, or tissue 1 0 2 0 0 389 Other/risk fctor not reported or identified 1 3 1 1 0 45 Totl b 124 115 109 69 48 9,443 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes children with dignosis of AIDS, from the beginning of the epidemic through 2004. b Includes children of unknown rce or multiple rces. Cumultive totl includes 24 children of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Figure 1. Estimted numbers of AIDS cses in children <13 yers of ge, by yer of dignosis, 1992 2004 United Sttes Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Reports of cses Cses of of AIDS, HIV/AIDS infection, nd AIDS nd HIV/AIDS 13

Tble 5. Estimted numbers of cses nd rtes (per 100,000 popultion) of AIDS, by rce/ethnicity, ge ctegory, nd sex, 2004 50 sttes nd the District of Columbi Adults or dolescents Mles Femles Totl Children (<13 yrs) Totl Rce/ethnicity No. Rte No. Rte No. Rte No. Rte No. Rte White, not Hispnic 10,118 12.3 1,860 2.1 11,978 7.1 7 0.0 11,985 6.0 Blck, not Hispnic 13,398 99.4 7,395 48.2 20,793 72.1 29 0.4 20,822 56.4 Hispnic 6,041 37.9 1,643 11.1 7,684 25.0 7 0.1 7,691 18.6 Asin/Pcific Islnder 392 7.5 92 1.6 484 4.4 1 0.1 486 3.7 Americn Indin/Alsk Ntive 128 13.5 64 6.4 192 9.9 1 0.2 193 7.9 Totl 30,203 25.6 11,109 9.0 41,312 17.1 46 0.1 41,359 14.1 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Dt exclude cses from the U.S. dependencies, possessions, nd ssocited ntions, s well s cses in persons whose stte or re of residence is unknown, becuse of the lck of census informtion by rce nd ge ctegories for these res. Includes persons of unknown rce or multiple rces. Totl includes 183 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Tble 5b. Estimted numbers of cses nd rtes (per 100,000 popultion) of HIV/AIDS, by rce/ethnicity, ge ctegory, nd sex, 2004 33 sttes with confidentil nme-bsed HIV infection reporting Adults or dolescents Mles Femles Totl Children (<13 yrs) Totl Rce/ethnicity No. Rte No. Rte No. Rte No. Rte No. Rte White, not Hispnic 10,010 18.7 1,782 3.2 11,791 10.7 9 0.0 11,801 9.0 Blck, not Hispnic 12,048 131.6 7,009 67.0 19,057 97.2 129 2.3 19,185 76.3 Hispnic 5,517 60.2 1,400 16.3 6,916 39.0 37 0.6 6,953 29.5 Asin/Pcific Islnder 299 13.9 94 4.1 393 8.9 0 0.0 393 7.2 Americn Indin/Alsk Ntive 148 20.8 57 7.7 205 14.1 1 0.3 206 11.1 Totl b 28,117 37.6 10,391 13.2 38,508 25.1 177 0.5 38,685 20.7 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 33 sttes hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, nd Wyoming. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Becuse row totls were clculted independently of vlues for the subpopultions, the vlue in ech row my not sum to the row totl. b Includes persons of unknown rce or multiple rces. Totl includes 146 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 14 Reports of Cses cses of HIV/AIDS AIDS, nd infection, AIDS nd HIV/AIDS

Tble 6. Estimted numbers of AIDS cses in dult nd dolescent Hispnics, by trnsmission ctegory nd plce of birth, 2004 United Sttes Plce of birth Centrl/South United Sttes Americ Cub Mexico Puerto Rico Totl Trnsmission ctegory No. % No. % No. % No. % No. % No. % Mle-to-mle sexul contct 1,182 43 437 52 121 59 860 60 313 20 3,642 42 Injection drug use 704 25 105 13 26 13 162 11 617 39 2,095 24 Mle-to-mle sexul contct nd injection drug use 147 5 19 2 9 5 48 3 66 4 352 4 Heterosexul contct 703 25 264 32 47 23 354 25 588 37 2,478 29 Other b 32 1 11 1 1 0 18 1 11 1 96 1 Totl c 2,769 100 836 100 204 100 1,443 100 1,595 100 8,663 100 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes 269 persons whose plce of birth is not mong those listed nd 1,548 persons whose plce of birth is unknown. Becuse row totls were clculted independently of the vlues for the subpopultions, the vlues in ech row my not sum to the row totl. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports of cses Cses of AIDS, of HIV/AIDS infection, nd AIDS nd HIV/AIDS 15

Tble 7. Estimted numbers of deths of persons with AIDS, by yer of deth nd selected chrcteristics, 2000 2004 United Sttes Yer of deth Cumultive 2000 2001 2002 2003 2004 through 2004 Age t deth (yrs) <13 52 46 32 28 18 5,094 13 14 8 4 11 7 16 266 15 19 41 44 39 43 32 1,055 20 24 167 215 167 175 184 8,808 25 29 710 635 595 569 505 44,516 30 34 1,993 1,744 1,555 1,373 1,157 96,357 35 39 3,346 3,292 3,108 2,969 2,404 116,206 40 44 3,523 3,835 3,726 3,800 3,378 100,633 45 49 3,081 3,121 3,364 3,432 3,016 67,842 50 54 1,966 2,152 2,396 2,524 2,314 39,936 55 59 1,007 1,141 1,228 1,403 1,343 22,452 60 64 593 655 621 726 701 12,946 65 652 728 702 801 730 13,004 Rce/ethnicity White, not Hispnic 5,325 5,194 5,210 5,091 4,316 229,220 Blck, not Hispnic 8,605 9,011 8,974 8,950 7,978 201,045 Hispnic 3,025 3,195 3,117 3,537 3,228 93,163 Asin/Pcific Islnder 95 100 91 81 82 3,272 Americn Indin/Alsk Ntive 66 81 84 73 91 1,578 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 5,955 6,068 6,016 5,990 5,450 256,053 Injection drug use 4,070 4,074 4,062 4,116 3,308 109,070 Mle-to-mle sexul contct nd injection drug use 1,324 1,366 1,323 1,322 1,180 39,467 Heterosexul contct 1,389 1,528 1,513 1,634 1,548 24,268 Other b 195 166 167 160 113 9,843 Subtotl 12,933 13,202 13,080 13,222 11,599 438,701 Femle dult or dolescent Injection drug use 1,892 1,907 1,977 1,989 1,744 41,178 Heterosexul contct 2,150 2,342 2,331 2,470 2,327 39,576 Other b 87 91 91 101 67 4,142 Subtotl 4,129 4,340 4,400 4,560 4,138 84,897 Child (<13 yrs t dignosis) Perintl 72 66 59 61 57 4,982 Other c 5 3 6 6 4 533 Subtotl 77 69 65 67 61 5,515 Region of residence Northest 5,200 5,130 5,213 5,654 4,019 169,693 Midwest 1,622 1,646 1,623 1,199 1,234 50,333 South 7,078 7,386 7,361 7,839 7,192 181,690 West 2,567 2,683 2,585 2,428 2,540 108,183 U.S. dependencies, possessions, nd ssocited ntions 672 766 763 730 814 19,214 Totl d 17,139 17,611 17,544 17,849 15,798 529,113 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Includes persons who died with AIDS, from the beginning of the epidemic through 2004. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes persons of unknown rce or multiple rces nd persons of unknown sex. Cumultive totl includes 836 persons of unknown rce or multiple rces. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 16 Reports of cses of AIDS, Deths HIV infection, nd HIV/AIDS

Tble 8. Estimted numbers of persons living with HIV/AIDS, by yer nd selected chrcteristics, 2001 2004 35 res with confidentil nme-bsed HIV infection reporting 2001 2002 2003 2004 Age s of end of yer (yrs) <13 4,838 4,598 4,187 3,713 13 14 830 950 1,123 1,239 15 19 2,745 2,968 3,301 3,683 20 24 11,500 12,033 12,582 13,371 25 29 25,334 25,768 26,538 27,836 30 34 52,672 51,896 50,416 49,133 35 39 82,539 83,133 81,891 80,086 40 44 79,325 86,422 93,414 99,742 45 49 59,008 65,879 72,498 79,728 50 54 34,929 40,488 45,932 52,658 55 59 16,271 19,550 23,286 27,571 60 64 7,781 9,497 11,098 13,170 65 6,674 7,816 9,099 10,861 Rce/ethnicity White, not Hispnic 133,475 141,120 148,459 157,172 Blck, not Hispnic 181,964 195,147 206,936 220,028 Hispnic 63,105 68,252 72,967 78,039 Asin/Pcific Islnder 1,796 2,084 2,415 2,765 Americn Indin/Alsk Ntive 1,587 1,728 1,865 1,996 Trnsmission ctegory Mle dult or dolescent Mle-to-mle sexul contct 159,937 172,502 184,778 199,085 Injection drug use 57,287 58,959 60,113 61,799 Mle-to-mle sexul contct nd injection drug use 21,643 22,201 22,688 23,337 Heterosexul contct 34,386 37,986 41,291 44,655 Other 3,445 3,524 3,602 3,702 Subtotl 276,698 295,172 312,472 332,578 Femle dult or dolescent Injection drug use 30,977 32,003 32,742 33,621 Heterosexul contct 68,173 74,925 81,007 87,262 Other 2,077 2,236 2,383 2,523 Subtotl 101,227 109,164 116,133 123,405 Child (<13 yrs t dignosis) Perintl 5,810 5,954 6,057 6,100 Other b 706 703 698 704 Subtotl 6,515 6,657 6,755 6,804 Totl c 384,446 410,998 435,364 462,792,,,, Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. b Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. c Includes persons of unknown rce or multiple rces nd persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. Reports Persons of living cses with of HIV/AIDS, infection, AIDS, or nd HIV HIV/AIDS infection 17

Tble 9. Estimted numbers of persons living with HIV/AIDS t the end of 2004, by rce/ethnicity, sex, nd trnsmission ctegory 35 res with confidentil nme-bsed HIV infection reporting Americn White, not Blck, not Asin/Pcific Indin/Alsk Hispnic Hispnic Hispnic Islnder Ntive Totl Trnsmission ctegory No. % No. % No. % No. % No. % No. % Mle dult or dolescent Mle-to-mle sexul contct 101,119 76 63,112 46 31,412 54 1,415 66 879 61 199,085 60 Injection drug use 12,750 10 33,237 24 14,990 26 267 12 218 15 61,799 19 Mle-to-mle sexul contct nd injection drug use 10,667 8 9,030 7 3,237 6 74 3 191 13 23,337 7 Heterosexul contct 6,260 5 29,458 22 8,109 14 334 16 146 10 44,655 13 Other b 1,580 1 1,617 1 411 1 50 2 18 1 3,702 1 Subtotl 132,376 100 136,454 100 58,159 100 2,141 100 1,452 100 332,578 100 Femle dult or dolescent Injection drug use 8,104 34 19,554 25 5,521 30 96 16 168 32 33,621 27 Heterosexul contct 15,256 64 57,991 73 12,636 68 470 79 347 66 87,262 71 Other b 481 2 1,626 2 357 2 30 5 10 2 2,523 2 Subtotl 23,841 100 79,170 100 18,513 100 596 100 525 100 123,405 100 Child (<13 yrs t dignosis) Perintl 793 83 4,013 91 1,228 90 23 85 18 95 6,100 90 Other c 161 17 389 9 138 10 4 15 1 5 704 10 Subtotl 953 100 4,402 100 1,366 100 27 100 19 100 6,804 100 Totl d 157,172 220,028 78,039 2,765 1,996 462,792 Note. These numbers do not represent reported cse counts. Rther, these numbers re point estimtes, which result from djustments of reported cse counts. The reported cse counts re djusted for reporting delys nd for redistribution of cses in persons initilly reported without n identified risk fctor. The estimtes do not include djustment for incomplete reporting. Dt include persons with dignosis of HIV infection. This includes persons with dignosis of HIV infection only, dignosis of HIV infection nd lter AIDS dignosis, nd concurrent dignoses of HIV infection nd AIDS. Since 2000, the following 35 res hve hd lws or regultions requiring confidentil nme-bsed HIV infection reporting: Albm, Alsk, Arizon, Arknss, Colordo, Florid, Idho, Indin, Iow, Knss, Louisin, Michign, Minnesot, Mississippi, Missouri, Nebrsk, Nevd, New Jersey, New Mexico, New York, North Crolin, North Dkot, Ohio, Oklhom, South Crolin, South Dkot, Tennessee, Texs, Uth, Virgini, West Virgini, Wisconsin, Wyoming, Gum nd the U.S. Virgin Islnds. Since July 1997, Florid hs hd confidentil nme-bsed HIV infection reporting only for new dignoses. Includes 2,793 persons of unknown rce or multiple rces. b Includes hemophili, blood trnsfusion, perintl, nd risk fctor not reported or not identified. c Includes hemophili, blood trnsfusion, nd risk fctor not reported or not identified. d Includes 5 persons of unknown sex. Becuse column totls were clculted independently of the vlues for the subpopultions, the vlues in ech column my not sum to the column totl. 18 Persons Reports living of cses with of HIV/AIDS, AIDS, infection, or HIV nd infection HIV/AIDS

Reports Persons of living cses with of HIV/AIDS, infection, AIDS, or nd HIV HIV/AIDS infection 19